Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations. - Marasco M; Kumar D; Garcia Borrego S; Seale T; Maddalena G; Mezzadra R; Belanger K; Cole S; Perez B; Luan W; Mukherjee R; Aricescu I; et al. (Cancer discovery, 2025)